Ep. 57 -  Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.